BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 28667064)

  • 1. Disposition and clinical implications of protein-bound uremic toxins.
    Jansen J; Jankowski J; Gajjala PR; Wetzels JFM; Masereeuw R
    Clin Sci (Lond); 2017 Jul; 131(14):1631-1647. PubMed ID: 28667064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kidney and uremic toxin removal: glomerulus or tubule?
    Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
    Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Dual Roles of Protein-Bound Solutes as Toxins and Signaling Molecules in Uremia.
    Masereeuw R
    Toxins (Basel); 2022 Jun; 14(6):. PubMed ID: 35737063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges of reducing protein-bound uremic toxin levels in chronic kidney disease and end stage renal disease.
    Faria M; de Pinho MN
    Transl Res; 2021 Mar; 229():115-134. PubMed ID: 32891787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs Commonly Applied to Kidney Patients May Compromise Renal Tubular Uremic Toxins Excretion.
    Mihaila SM; Faria J; Stefens MFJ; Stamatialis D; Verhaar MC; Gerritsen KGF; Masereeuw R
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32545617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using binding competitors of albumin to promote the removal of protein-bound uremic toxins in hemodialysis: Hope or pipe dream?
    Florens N; Yi D; Juillard L; Soulage CO
    Biochimie; 2018 Jan; 144():1-8. PubMed ID: 28987629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction.
    Cunha RSD; Azevedo CAB; Falconi CA; Ruiz FF; Liabeuf S; Carneiro-Ramos MS; Stinghen AEM
    Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
    Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapeutic perspectives on protein-bound uremic toxins in chronic kidney disease.
    Malyszko J
    Expert Opin Ther Targets; 2014 Feb; 18(2):109-13. PubMed ID: 24283253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future Avenues to Decrease Uremic Toxin Concentration.
    Vanholder RC; Eloot S; Glorieux GL
    Am J Kidney Dis; 2016 Apr; 67(4):664-76. PubMed ID: 26500179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
    Black AP; Cardozo LF; Mafra D
    Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier perturbations by uremic toxins: Key contributors in chronic kidney disease-induced neurological disorders?
    Faucher Q; van der Made TK; De Lange E; Masereeuw R
    Eur J Pharm Sci; 2023 Aug; 187():106462. PubMed ID: 37169097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins.
    Ciceri P; Cozzolino M
    Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34073439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal versus continuous versus intermittent therapies for removal of uremic toxins.
    Clark WR; Henderson LW
    Kidney Int Suppl; 2001 Feb; 78():S298-303. PubMed ID: 11169030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Uremic Solutes on the Organic Cation Transporter 2.
    Cheung KWK; Hsueh CH; Zhao P; Meyer TW; Zhang L; Huang SM; Giacomini KM
    J Pharm Sci; 2017 Sep; 106(9):2551-2557. PubMed ID: 28483424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees.
    Rapp N; Evenepoel P; Stenvinkel P; Schurgers L
    Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 33003628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uremic toxins: a new focus on an old subject.
    Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
    Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance.
    Daneshamouz S; Eduok U; Abdelrasoul A; Shoker A
    NanoImpact; 2021 Jan; 21():100299. PubMed ID: 35559786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing transporters to clear uremic toxins.
    Moe OW
    J Am Soc Nephrol; 2009 Dec; 20(12):2483-4. PubMed ID: 19926890
    [No Abstract]   [Full Text] [Related]  

  • 20. Extracorporeal removal of uremic toxins: can we still do better?
    Eloot S; Ledebo I; Ward RA
    Semin Nephrol; 2014 Mar; 34(2):209-27. PubMed ID: 24780474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.